Display Settings:

Format
Items per page

Send to:

Choose Destination

Results: 7

1.

Provera

brand name of a synthetic female sex hormone [from CHV]

MedGen UID:
148543
Concept ID:
C0699702
Pharmacologic Substance
2.

Nafoxidine

An estrogen antagonist that has been used in the treatment of breast cancer. [from MeSH]

MedGen UID:
10254
Concept ID:
C0027328
Pharmacologic Substance
3.

Medroxyprogesterone

A synthetic derivative of progesterone administered as an acetate salt (medroxyprogesterone acetate) with antiestrogenic activity. As a do all progestins, medroxyprogesterone binds to and activates nuclear receptors which subsequently bind to and activate target genes for transcription. As an antiestrogen, this agent may inhibit the growth-stimulating effects of estrogen on estrogen-sensitive tumor cells. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=39813&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=39813&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C629" NCI Thesaurus) [from PDQ]

MedGen UID:
6282
Concept ID:
C0025147
Pharmacologic Substance
4.

hydroxyurea

An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. [from MeSH]

MedGen UID:
5683
Concept ID:
C0020402
Pharmacologic Substance
5.

Renal cell carcinoma

A type of carcinoma of the kidney with origin in the epithelium of the proximal convoluted renal tubule. [from HPO]

MedGen UID:
505836
Concept ID:
CN004944
Finding
6.

Renal Carcinoma

A carcinoma arising from the epithelium of the renal parenchyma (renal cell carcinoma) or the renal pelvis (renal pelvis carcinoma). The vast majority of renal cell carcinomas are adenocarcinomas. The vast majority of renal pelvis carcinomas are transitional cell carcinomas. Renal carcinomas usually affect middle aged and elderly adults. Hematuria, abdominal pain, and a palpable mass are common symptoms. -- 2004 [from NCI]

MedGen UID:
235133
Concept ID:
C1378703
Neoplastic Process
7.

U-11,100A

MedGen UID:
183050
Concept ID:
C0919376
Pharmacologic Substance

Display Settings:

Format
Items per page

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...